Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 2, 2007, Pages 89-90

  Enright, Paul ^a   Quanjer, Philip ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ACCURACY; AGING; AIRWAY OBSTRUCTION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DECISION MAKING; EDITORIAL; HUMAN; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SCREENING; SPIROMETRY; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; VITAL CAPACITY;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 34547451151     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550701341509     Document Type: Editorial

References (18)

1. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al, on behalf of the PLATINO group. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; in press.
2. Perez-Padilla R, Vazquez-Garcia JC, Marquez MN, Jardim JR, Pertuze J, Lisboa C, Muino A, Lopez MV, Talamo C, de Oca MM, Valdivia G, Menezes AM; Latin American COPD Prevalence Study (PLATINO) Team. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2006; 51(10):1167-1171.
3. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, Crapo RO, Jensen RL, Burney PG. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005 Jun; 2(2):277-283.
4. US Wellness. Are you a respiratory therapist with spirometry experience? Consider joining the US Wellness network of health care professionals.〈www.nrtc-usa.org/CareerOpportunities.html〉 and 〈www.uswellness.com〉 Accessed March 6, 2007.
5. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146-1161.
6. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
7. Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006 Jun; 3(2):95-100.
8. Quanjer P. For the Falling Ratio Working Group. FEV1% predicted versus Lower Limit of Normal for FEV1. 〈www.spirxpert.com/controversies/ controversy1.html〉, accessed March 10, 2007.
9. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2006 Update. 〈www.goldcopd.com〉 (Accessed March 10, 2006).
10. AHRQ Minnesota Evidence-based Practice Center of the Agency for Healthcare Research and Quality. Use of Spirometry for Case Finding, Diagnosis, and Management of COPD. Publication No. 05-E017-2, August 2005. 〈http://www.ahrq.gov/clinic/tp/spirotp.htm〉 Accessed March 7, 2007.
11. Albers M, Schermer T, van den Boom G, et al. Efficacy of inhaled corticosteroids in undiagnosed subjects at high risk for COPD. Chest 2004; 126:1815-1824.
12. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good? Chest 2006 Apr; 129(4):833-835.
13. Naberan K, delaRoza C, Lamban M, Bobartt E, Martin A, Miravitlles M. Use of spirometry in the diagnosis and treatment of COPD in primary care. Arch Bronconeumol 2006; 42:638-644.
14. Lusuardi M, de Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in tandard office practice. Chest 2006; 129:844-852.
15. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest 2006; 129(6):1509-1515.
16. Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47:429-436.
17. Dompeling E, Van Schayck CP, Molema J, et al. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD: reproducibility and dependence of prebronchodilator FEV1. Eur Respir J 1992; 5:975-981.
18. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW, for the ISOLDE Study Investigators. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58:659-664.